IDEXX Laboratories, Inc.  

(Public, NASDAQ:IDXX)   Watch this stock  
Find more results for IDXX
155.60
+0.01 (0.01%)
Real-time:   11:50AM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 154.80 - 157.07
52 week 113.47 - 173.01
Open 155.93
Vol / Avg. 82,748.00/550,156.00
Mkt cap 13.57B
P/E 50.45
Div/yield     -
EPS 3.08
Shares 87.22M
Beta 0.46
Inst. own 108%
Feb 14, 2018
Q4 2017 IDEXX Laboratories Inc Earnings Release (Estimated) - 7:00AM EST - Add to calendar
Oct 31, 2017
Q3 2017 IDEXX Laboratories Inc Earnings Call - Webcast
Oct 31, 2017
Q3 2017 IDEXX Laboratories Inc Earnings Release
Sep 13, 2017
IDEXX Laboratories Inc at Bank of America Merrill Lynch Health Care Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 14.33% 12.51%
Operating margin 20.41% 19.73%
EBITD margin - 24.13%
Return on average assets 17.11% 14.78%
Return on average equity - -
Employees 7,365 -
CDP Score - -

Address

1 Idexx Dr
WESTBROOK, ME 04092-2041
United States - Map
+1-207-5560300 (Phone)
+1-207-5564346 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services for the companion animal veterinary, livestock and poultry, dairy and water testing markets. The Company also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include diagnostic and information technology-based products and services for the veterinary market, which the Company refers to as the Companion Animal Group; water quality products; diagnostic products and services for livestock and poultry health, which the Company refers to as Livestock, Poultry and Dairy, and Other operating segment, which combines and presents products for the human point-of-care medical diagnostics market with its pharmaceutical product line and its out-licensing arrangements. Its products and services include point-of-care veterinary diagnostic products, comprising instruments, consumables and rapid assay test kits, among others.

Officers and directors

Jonathan W. Ayers Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian P. McKeon Chief Financial Officer, Executive Vice President, Treasurer
Age: 54
Bio & Compensation  - Reuters
Giovani Twigge Chief Human Resource Officer, Corporate Vice President
Age: 53
Bio & Compensation  - Reuters
Jay Mazelsky Executive Vice President
Age: 56
Bio & Compensation  - Reuters
Jacqueline L. Studer Corporate Vice President, General Counsel, Corporate Secretary
Age: 58
Bio & Compensation  - Reuters
William T. End Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
Bruce L Claflin Independent Director
Age: 65
Bio & Compensation  - Reuters
Stuart M. Essig Ph.D. Independent Director
Age: 55
Bio & Compensation  - Reuters
Rebecca M. Henderson Ph.D. Independent Director
Age: 56
Bio & Compensation  - Reuters
Daniel M. Junius Independent Director
Age: 64
Bio & Compensation  - Reuters